ONCONETIX INC (ONCO)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$0.55-16.60%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · ONCO
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -77.5% |
| Our one-year growth estimate | diamond | 40.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 117.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name has been missing across recent quarters and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 117 industry peers
ONCO — litigation filed
Dated 2026-11-05
Entry into a Material Definitive Agreement. First Amendment to Share Exchange Agreement As previously disclosed, on February 11, 2026, Onconetix, Inc., a Delaware corporation (“ Onconetix ” or “ Buyer ”), entered into a Share Exchange Agreement (the “ Share Exchange Agreement ”), by and among (i) Onconetix, (ii) Realbotix Corp., a company existing under the laws of the Province of Ontario (“ Parent ”), (iii) Simulacra Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent…
Why it matters: Revenue fell from $21,457 in Q1 to $17,120 in Q2. The supplied data do not break out Proclarix sales, so the report can show whether sales are growing.
Watch forThe Nov. 12 report shows revenue above $17,120 and names Proclarix sales or product volume as a source of growth.
Also watch forThe report shows revenue at or below $17,120 and gives no Proclarix sales or volume growth.
Why it matters: The deal is still pending, and Onconetix has advanced $2.5 million to Realbotix. Closing would complete the main growth plan described in the filings.
Watch forAn SEC filing or company release says the share exchange closed. Stockholders and regulators approved it.
Also watch forThe share exchange agreement ends, or a filing says closing terms were not met by a stated deadline.
Why it matters: The advance helps fund Realbotix before closing. If the deal ends, the note bears 12% interest from termination.
Worry ifA filing says the deal ended. The $2.5 million advance is still due, with 12% interest from termination.
Less concerning ifA filing says the deal closed and the note was canceled and discharged in full.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$471 on $10,000 · ±4.7% | How much price usually moves either way. |
| Bad day | $1,802 loss on $10,000 · 18.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,974 loss on $10,000 · 99.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.